A detailed history of Corton Capital Inc. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Corton Capital Inc. holds 17,051 shares of WVE stock, worth $176,648. This represents 0.12% of its overall portfolio holdings.

Number of Shares
17,051
Previous 40,869 58.28%
Holding current value
$176,648
Previous $335,000 37.31%
% of portfolio
0.12%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$8.0 - $16.44 $190,544 - $391,567
-23,818 Reduced 58.28%
17,051 $210,000
Q3 2024

Nov 14, 2024

BUY
$5.12 - $9.01 $209,249 - $368,229
40,869 New
40,869 $335,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $899M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.